Teriparatide vs Ac-SDKP
Head-to-head comparison of Teriparatide (Parathyroid Hormone (1-34)) and Ac-SDKP (N-Acetyl-Seryl-Aspartyl-Lysyl-Proline) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Teriparatide | Ac-SDKP |
|---|---|---|
| Category | Recovery & Healing | Recovery & Healing |
| Full Name | Parathyroid Hormone (1-34) | N-Acetyl-Seryl-Aspartyl-Lysyl-Proline |
| Molecular Weight | 4117 Da | 432.4 Da |
| Half-Life | about 1 hour | minutes |
| Amino Acids | 34 | 4 |
| Typical Dose | 20 mcg daily | 10–100 µg/kg/day in pre-clinical studies |
| Route | Subcutaneous | Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 1200 | 180 |
| Research Status | Clinical | Pre-clinical |
Teriparatide Benefits
- ✓stimulates bone formation
- ✓supports fracture union
- ✓improves bone mineral density
- ✓may aid bone remodeling
Ac-SDKP Benefits
- ✓anti-inflammatory tissue remodeling
- ✓fibroblast modulation
- ✓microvascular protection
- ✓faster regenerative signaling
Teriparatide Dosing
20 mcg subcutaneous daily|intermittent anabolic exposure|monitor calcium and vitamin D status
Ac-SDKP Dosing
Research-only systemic microdoses|short daily dosing in animal models|route varies by study
Teriparatide Side Effects
- ⚠hypercalcemia
- ⚠nausea
- ⚠dizziness
Ac-SDKP Side Effects
- ⚠GI upset
- ⚠hypotension at high exposure
- ⚠unknown long-term safety
Research Overview
Teriparatide
Teriparatide has extensive clinical literature showing anabolic effects on bone and investigational use in delayed unions and nonunions. It is one of the best-studied peptide-based options for skeletal recovery.
Ac-SDKP
Ac-SDKP has literature in tissue remodeling, angiogenesis, and organ repair models. Its strongest evidence is pre-clinical, where it modulates inflammation and fibrosis during healing.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.